Ledger.Open graph →
SEC Form D · Amendment · filed October 11, 2022

Bryn Pharma, LLC

Offering
$50.0M
Sold
$43.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Michelle Lobel · Raleigh, NCExec · DirectorSteven Hartman · Raleigh, NCExec · DirectorKatherine Grell · Raleigh, NCDirectorDavid Dworaczyk · Raleigh, NCExec · DirectorRobert Yanez · Raleigh, NCExecHeather Raines · Knoxville, TNDirectorMartin Devenport · Rockville, MDExec · DirectorKun-Liang Guan · Rockville, MDExec · DirectorRajul Garg · Singapore, U0Exec · DirectorTremblant Capital LP · Stamford, CTExecSwan E. Sit · EMERYVILLE, CAExec · DirectorXiaopei (Ray) Wang · EMERYVILLE, CAExec · DirectorAndrew M. Jones · EMERYVILLE, CAExec · DirectorTravis M. Joyner · Hamilton, MTDirectorMike Palm · Grand Rapids, MIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗